Kidney transplant patients may think clearer with once-daily pill switch
NCT ID NCT04838288
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 56 stable kidney transplant patients to see if switching their anti-rejection medication from twice-daily tacrolimus to once-daily Envarsus XR improved their thinking skills and quality of life. Participants took tests of memory, attention, and reasoning before and after the switch. The goal was to find out if the new drug could reduce brain fog and make daily life better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL TRANSPLANT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
VUMC
Nashville, Tennessee, 37232, United States